Business | NDTV Correspondent | Friday November 25, 2011
Sun Pharmaceutical Industries on June 18 said that it has received the US Food and Drug Administration's (USFDA) nod to market a generic version of alprazolam, an anti-anxiety drug, in the US market.
The company has received the USFDA's nod for marketing generic alprazolam tablets in four strengths -- 0.25 mg, 0.55 mg, 1 mg and 2 mg -- in t...
www.ndtv.com/business